Anti-IL-4Ralpha monoclonal antibody dupilumab mimics ulcerative colitis: a case report.

This is a first report that dupilumab mimicked ulcerative colitis. Careful monitoring for adverse effects with the onset of an intestinal inflammation will be recommended after dupilumab administration.